“The Integrated 31-Gene Expression Profile Test (i31-GEP) for Cutaneous Melanoma Outperforms the CP-GEP at Identifying Patients Who Can Forego Sentinel Lymph Node Biopsy When Applying NCCN Guidelines”. SKIN The Journal of Cutaneous Medicine 6, no. 6 (November 16, 2022): 474–481. Accessed April 30, 2026. https://skin.dermsquared.com/skin/article/view/1796.